These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33824218)

  • 1. [Migraine Mechanisms: In Relation to the Premonitory Phase and CGRP/CGRP Receptor Antagonists].
    Awaki E; Takeshima T
    Brain Nerve; 2021 Apr; 73(4):303-313. PubMed ID: 33824218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
    Chen ST; Wu JW
    Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
    Durham PL; Vause CV
    CNS Drugs; 2010 Jul; 24(7):539-48. PubMed ID: 20433208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGRP and the Trigeminal System in Migraine.
    Iyengar S; Johnson KW; Ossipov MH; Aurora SK
    Headache; 2019 May; 59(5):659-681. PubMed ID: 30982963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
    Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
    Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGRP antagonists: hope for a new era in acute migraine treatment.
    Schelstraete C; Paemeleire K
    Acta Neurol Belg; 2009 Dec; 109(4):252-61. PubMed ID: 20120204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.
    Raddant AC; Russo AF
    Expert Rev Mol Med; 2011 Nov; 13():e36. PubMed ID: 22123247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the brainstem in migraine: Potential brainstem effects of CGRP and CGRP receptor activation in animal models.
    Holland PR; Saengjaroentham C; Vila-Pueyo M
    Cephalalgia; 2019 Mar; 39(3):390-402. PubMed ID: 29411638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin gene-related peptide (CGRP): a new target for migraine.
    Russo AF
    Annu Rev Pharmacol Toxicol; 2015; 55():533-52. PubMed ID: 25340934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGRP receptor antagonism and migraine therapy.
    Edvinsson L; Warfvinge K
    Curr Protein Pept Sci; 2013 Aug; 14(5):386-92. PubMed ID: 23745702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.
    Durham PL
    Headache; 2008 Sep; 48(8):1269-75. PubMed ID: 18808507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
    Hargreaves R; Olesen J
    Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
    Edvinsson L; Warfvinge K
    Cephalalgia; 2019 Mar; 39(3):366-373. PubMed ID: 29020807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin Gene-Related Peptide Antagonists in the Treatment of Episodic Migraine.
    Yuan H; White CS; Silberstein SD
    Clin Pharmacol Ther; 2019 May; 105(5):1121-1129. PubMed ID: 30648737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcitonin gene-related peptide: a key player neuropeptide in migraine].
    Ramos-Romero ML; Sobrino-Mejia FE
    Rev Neurol; 2016 Nov; 63(10):460-468. PubMed ID: 27819404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
    Edvinsson L; Haanes KA; Warfvinge K; Krause DN
    Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGRP mechanism antagonists and migraine management.
    Karsan N; Goadsby PJ
    Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody.
    Melo-Carrillo A; Noseda R; Nir RR; Schain AJ; Stratton J; Strassman AM; Burstein R
    J Neurosci; 2017 Jul; 37(30):7149-7163. PubMed ID: 28642283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained Effects of CGRP Blockade on Cortical Spreading Depolarization-Induced Alterations in Facial Heat Pain Threshold, Light Aversiveness, and Locomotive Activity in the Light Environment.
    Kitagawa S; Tang C; Unekawa M; Kayama Y; Nakahara J; Shibata M
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CGRP receptor antagonists: toward a novel migraine therapy.
    Salvatore CA; Kane SA
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1671-80. PubMed ID: 21466447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.